Nanocarriers for Pulmonary Administration of Peptides and Therapeutic Proteins

• Umashankar M , Sachdeva, Gulati M: Aquasomes: a promising carrier for peptides and protein delivery. Nanomedicine6, 419–426 (2010).
   PubMed Web of Science ®Google Scholar
• Klingler C , MüllerB, SteckelH: Insulin-micro- and nanoparticles for pulmonary delivery.Int. J. Pharm.377(1–2), 173–179 (2009).
   PubMedGoogle Scholar
• Amidi M , MastrobattistaE, JiskootW, HenninkW: Chitosan-based delivery systems for protein therapeutics and antigens.Adv. Drug Deliv. Rev.62(1), 59–82 (2010).
   PubMed Web of Science ®Google Scholar
• Sarmento B , RibeiroA, VeigaF, FerreiraD: Development and characterization of new insulin containing polysaccharide nanoparticles.Colloids Surf. B Biointerfaces53(2), 193–202 (2006).
   PubMed Web of Science ®Google Scholar
• Bayat A , DorkooshF, DehpourAet al.: Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.Int. J. Pharm.356(1–2), 259–266 (2008).
   PubMedGoogle Scholar
• Bailey M , BerklandC: Nanoparticle formulations in pulmonary drug delivery.Med. Res. Rev.29(1), 196–212 (2009).
   PubMed Web of Science ®Google Scholar
• Nyambura B , KellawayI, TaylorK: Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.Int. J. Pharm.375(1–2), 114–122 (2009).
   PubMedGoogle Scholar
• Sung J , PulliamB, EdwardsD: Nanoparticles for drug delivery to the lungs.Trends Biotechnol.25(12), 563–570 (2007).
   PubMed Web of Science ®Google Scholar
• Soppimath K , AminabhaviT, KulkarniA, RudzinskiW: Biodegradable polymeric nanoparticles as drug delivery devices.J. Control. Release70(1–2), 1–20 (2001).
   PubMed Web of Science ®Google Scholar
• Martins S , SarmentoB, FerreiraD, SoutoE: Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles.Int. J. Nanomedicine2(4), 595–607 (2007).
   PubMed Web of Science ®Google Scholar
• Tauzin B : Biotechnology Medicines in Development. Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, DC, USA (2008).
   Google Scholar
• EvaluatePharma®: World preview to 2016. EvaluatePharma Ltd, London, UK (2010).
   Google Scholar
• Tang L , MeibohmB: Pharmacokinetics of peptides and proteins. In: Pharmacokinetics and Pharmacodynamics of Biotech Drugs – Principles and Case Studies in Drug Development.. Meibohm B (Ed.). Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany (2006).
   Google Scholar
• Hillery A : Drug delivery: The basic concepts. In: Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. Hillery A, Lloyd A, Swarbrick J (Eds). Taylor & Francis, London, UK (2001).
   Google Scholar
• Morishita M , PeppasN: Is the oral route possible for peptide and protein drug delivery?Drug Discov. Today11(19–20), 905–910 (2006).
   PubMed Web of Science ®Google Scholar
• Antosova Z , MackovaM, KralV, MacekT: Therapeutic application of peptides and proteins: parenteral forever?Trends Biotechnol.27(11), 628–635 (2009).
   PubMed Web of Science ®Google Scholar
• Cryan S : Carrier-based strategies for targeting protein and peptide drugs to the lungs.AAPS J.7(1), E20–E41 (2005).
   PubMed Web of Science ®Google Scholar
• Cryan S , SivadasN, Garcia-ContrerasL: In vivo animal models for drug delivery across the lung mucosal barrier.Adv. Drug Deliv. Rev.59(11), 1133–1151 (2007).
   PubMed Web of Science ®Google Scholar
• Iazzetti G , RiguttiE (Eds): Atlas of Anatomy. Taj Books, Surrey, UK (2005).
   Google Scholar
• Yang W , PetersJ, WilliamsRR: Inhaled nanoparticles – a current review.Int. J. Pharm.356(1–2), 239–247 (2008).
   PubMedGoogle Scholar
• Groneberg D , FischerA, ChungK, DanielH: Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.Am. J. Respir. Cell Mol. Biol.30(3), 251–260 (2004).
   PubMed Web of Science ®Google Scholar
• Grenha A , Carrión-RecioD, Teijeiro-OsorioD, SeijoB, Remuñán-LópezC (Eds): Nano and Microparticulate Carriers for Pulmonary Drug Delivery. American Scientific Publishers, Valencia, CA, USA (2008).
   Google Scholar
• Tomoda K , OhkoshiT, NakajimaT, MakinoK: Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles.Colloids Surf. B Biointerfaces64(1), 70–76 (2008).
   PubMed Web of Science ®Google Scholar
• Smola M , VandammeT, SokolowskiA: Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.Int. J. Nanomedicine3(1), 1–19 (2008).
   PubMed Web of Science ®Google Scholar
• Cefalu W : Concept, strategies, and feasibility of noninvasive insulin delivery.Diabetes Care27(1), 239–246 (2004).
   PubMed Web of Science ®Google Scholar
• Kim K , MalikA: Protein transport across the lung epithelial barrier.Am. J. Physiol Lung Cell. Mol. Physiol.284(2), L247–L259 (2003).
   PubMed Web of Science ®Google Scholar
• Hastings R , FolkessonH, MatthayM: Mechanisms of alveolar protein clearance in the intact lung.Am. J. Physiol. Lung Cell Mol. Physiol.286(4), L679–L689 (2004).
   PubMed Web of Science ®Google Scholar
• Berthiaume Y , AlbertineK, GradyM, FickG, MatthayM: Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h.J. Appl. Physiol.67(5), 1887–1897 (1989).
   PubMed Web of Science ®Google Scholar
• Agu R , UgwokeM, ArmandM, KingetR, VerbekeN: The lung as a route for systemic delivery of therapeutic proteins and peptides.Respir. Res.2(4), 198–209 (2001).
   PubMed Web of Science ®Google Scholar
• Pezron I , MitraR, PalD, MitraA: Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (calu-3).J. Pharm. Sci.91(4), 1135–1146 (2002).
   PubMed Web of Science ®Google Scholar
• Folkesson H , WeströmB, KarlssonB: Permeability of the respiratory tract to different-sized macromolecules after intratracheal instillation in young and adult rats.Acta Physiol. Scand.139(2), 347–354 (1990).
   PubMedGoogle Scholar
• Conhaim R , WatsonK, Lai-FookS, HarmsB: Transport properties of alveolar epithelium measured by molecular hetastarch absorption in isolated rat lungs.J. Appl. Physiol.91(4), 1730–1740 (2001).
   PubMed Web of Science ®Google Scholar
• Holter J , WeilandJ, PachtE, GadekJ, DavisW: Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium.J. Clin. Invest.78(6), 1513–1522 (1986).
   PubMed Web of Science ®Google Scholar
• Matsukawa Y , YamaharaH, YamashitaF, LeeV, CrandallE, KimK: Rates of protein transport across rat alveolar epithelial cell monolayers.J. Drug Target7(5), 335–342 (2000).
   PubMed Web of Science ®Google Scholar
• Bahadduri P , D‘souzaV, PinsonneaultJet al.: Functional characterization of the peptide transporter pept2 in primary cultures of human upper airway epithelium.Am. J. Respir. Cell Mol. Biol.32(4), 319–325 (2005).
   PubMed Web of Science ®Google Scholar
• Islam N , GladkiE: Dry powder inhalers (DPIs) – a review of device reliability and innovation.Int. J. Pharm.360(1–2), 1–11 (2008).
   PubMedGoogle Scholar
• Brunton L , LazoJ, ParkerK (Eds): Goodman & Gilman‘s The Pharmacological Basis of therapeutics. McGraw-Hill Professional, Berkshire, UK (2006).
   Google Scholar
• Katzung B (Ed.): Basic & Clinical Pharmacology. Lange Medical Books/McGraw-Hill, New York, NY, USA (2001).
   Google Scholar
• Cheng K , MahatoR: Biopharmaceutical challenges: pulmonary delivery of proteins and peptides. In: Pharmacokinetics and Pharmacodynamics of Biotech Drugs – Principles and Case Studies in Drug Development, Meibohm B (Ed.): Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany (2006).
   Google Scholar
• Wolzt M , De La Peña A, Berclaz P, Tibaldi F, Gates J, Muchmore D: Air inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma. Diabetes Care31(4), 735–740 (2008).
   PubMed Web of Science ®Google Scholar
• De Galan B , SimsekS, TackC, HeineR: Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.Neth. J. Med.64(9), 319–325 (2006).
   PubMed Web of Science ®Google Scholar
• Skyler J , CefaluW, KouridesIet al.: Efficacy of inhaled human insulin in Type 1 diabetes mellitus: a randomised proof-of-concept study.Lancet357(9253), 331–335 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenstock J , CefaluW, HollanderPet al.: Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with Type 2 diabetes.Diabetes Care31(9), 1723–1728 (2008).
   PubMed Web of Science ®Google Scholar
• Karathanasis E , BhavaneR, AnnapragadaA: Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.Int. J. Nanomedicine2(3), 501–513 (2007).
   PubMed Web of Science ®Google Scholar
• Ungaro F , D‘emmanuele Di Villa Bianca R, Giovino C et al.: Insulin-loaded plga/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release135(1), 25–34 (2009).
   PubMed Web of Science ®Google Scholar
• Garg S , KellyW: Insulin delivery via lungs – is it still possible?Diabetes Technol. Ther.11(2 Suppl. 2), S1–S3 (2009).
   PubMedGoogle Scholar
• Peppas N , CarrD: Impact of absorption and transport on intelligent therapeutics and nano-scale delivery of protein therapeutic agents.Chem. Eng. Sci.64(22), 4553–4565 (2009).
   PubMed Web of Science ®Google Scholar
• Lee Y , SinkoP: Oral delivery of salmon calcitonin.Adv. Drug Deliv. Rev.42(3), 225–238 (2000).
   PubMed Web of Science ®Google Scholar
• Patton J : Pulmonary delivery of drugs for bone disorders.Adv. Drug Deliv. Rev.42(3), 239–248 (2000).
   PubMed Web of Science ®Google Scholar
• Deftos L , NolanJ, SeelyBet al.: Intrapulmonary drug delivery of salmon calcitonin.Calcif. Tissue Int.61(4), 345–347 (1997).
   PubMed Web of Science ®Google Scholar
• Yamamoto A , OkumuraS, FukudaY, FukuiM, TakahashiK, MuranishiS: Improvement of the pulmonary absorption of (asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.J. Pharm. Sci.86(10), 1144–1147 (1997).
   PubMed Web of Science ®Google Scholar
• Waldrep J , ArppeJ, JansaK, VidgrenM: Experimental pulmonary delivery of cyclosporin a by liposome aerosol.Int. J. Pharm.160, 239–249 (1998).
   Web of Science ®Google Scholar
• Mitruka S , PhamS, ZeeviAet al.: Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation.J. Thorac. Cardiovasc. Surg.115(1), 28–36, discussion 36–27 (1998).
   PubMed Web of Science ®Google Scholar
• Keenan R , IaconoA, DauberJet al.: Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients.J. Thorac. Cardiovasc. Surg.113(2), 335–340, discussion 340–331 (1997).
   PubMed Web of Science ®Google Scholar
• Letsou G , SafiH, ReardonMet al.: Pharmacokinetics of liposomal aerosolized cyclosporine a for pulmonary immunosuppression.Ann. Thorac. Surg.68(6), 2044–2048 (1999).
   PubMed Web of Science ®Google Scholar
• Thipphawong J : Inhaled cytokines and cytokine antagonists.Adv. Drug Deliv. Rev.58(9–10), 1089–1105 (2006).
   PubMed Web of Science ®Google Scholar
• Skubitz K , AndersonP: Inhalational interleukin-2 liposomes for pulmonary metastases: a Phase I clinical trial.Anticancer Drugs11(7), 555–563 (2000).
   PubMed Web of Science ®Google Scholar
• Huland E , HeinzerH: Renal cell carcinoma – innovative medical treatments.Curr. Opin. Urol.14(4), 239–244 (2004).
   PubMed Web of Science ®Google Scholar
• Huland E , BurgerA, FleischerJet al.: Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.Folia Biol. (Praha)49(5), 183–190 (2003).
   PubMed Web of Science ®Google Scholar
• Heinzer H , MirT, HulandE, HulandH: Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy.J. Clin. Oncol.17(11), 3612–3620 (1999).
   PubMed Web of Science ®Google Scholar
• Hartig S , GreeneR, DasguptaJet al.: Multifunctional nanoparticulate polyelectrolyte complexes.Pharm. Res.24(12), 2353–2369 (2007).
   PubMed Web of Science ®Google Scholar
• Mishra B , PatelB, TiwariS: Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.Nanomedicine6(1), 9–24 (2010).
   PubMed Web of Science ®Google Scholar
• Crowder T , RosatiJ, SchroeterJ, HickeyA, MartonenT: Fundamental effects of particle morphology on lung delivery: predictions of stokes’ law and the particular relevance to dry powder inhaler formulation and development.Pharm. Res.19(3), 239–245 (2002).
   PubMed Web of Science ®Google Scholar
• Oberdörster G , OberdörsterE, OberdörsterJ: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.Environ. Health Perspect.113(7), 823–839 (2005).
   PubMed Web of Science ®Google Scholar
• Azarmi S , TaoX, ChenHet al.: Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.Int. J. Pharm.319(1–2), 155–161 (2006).
   PubMedGoogle Scholar
• Vega-Villa K , TakemotoJ, YáñezJ, RemsbergC, ForrestM, DaviesN: Clinical toxicities of nanocarrier systems.Adv. Drug Deliv. Rev.60(8), 929–938 (2008).
   PubMed Web of Science ®Google Scholar
• Kawashima Y , YamamotoH, TakeuchiH, FujiokaS, HinoT: Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.J. Control. Release62(1–2), 279–287 (1999).
   PubMed Web of Science ®Google Scholar
• Grenha A , SeijoB, Remuñán-LópezC: Microencapsulated chitosan nanoparticles for lung protein delivery.Eur. J. Pharm. Sci.25(4–5), 427–437 (2005).
   PubMed Web of Science ®Google Scholar
• Semmler-Behnke M , TakenakaS, FertschSet al.: Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent reentrainment onto airways epithelium.Environ. Health Perspect.115(5), 728–733 (2007).
   PubMed Web of Science ®Google Scholar
• Dailey L , JekelN, FinkLet al.: Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.Toxicol. Appl. Pharmacol.215(1), 100–108 (2006).
   PubMed Web of Science ®Google Scholar
• Azarmi S , RoaW, LöbenbergR: Targeted delivery of nanoparticles for the treatment of lung diseases.Adv. Drug Deliv. Rev.60(8), 863–875 (2008).
   PubMed Web of Science ®Google Scholar
• Kathuria H , CaoY, RamirezM, WilliamsM: Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ets proteins in epithelial cell expression.J. Biol. Chem.279(29), 30028–30036 (2004).
   PubMed Web of Science ®Google Scholar
• Roy I , VijN: Nanodelivery in airway diseases: challenges and therapeutic applications.Nanomedicine6(2), 237–244 (2010).
   PubMed Web of Science ®Google Scholar
• Brandenberger C , MühlfeldC, AliZet al.: Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles.Small6(15), 1669–1678 (2010).
   PubMed Web of Science ®Google Scholar
• Zhu M , FengW, WangYet al.: Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment.Toxicol. Sci.107(2), 342–351 (2009).
   PubMed Web of Science ®Google Scholar
• Möller W , FeltenK, SommererKet al.: Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.Am. J. Respir. Crit. Care Med.177(4), 426–432 (2008).
   PubMed Web of Science ®Google Scholar
• Arppe J , VidgrenM, WaldrepJC: Pulmonary pharmacokinetics of cyclosporin a liposomes.Int. J. Pharm.161, 205–214 (1998).
   Web of Science ®Google Scholar
• Herber-Jonat S , MittalR, GsinnS, BohnenkampH, GuenziE, SchulzeA: Comparison of lung accumulation of cationic liposomes in normal rats and lps-treated rats.Inflamm. Res. DOI 10.1007/s00011-010-0260-y (2010) (Epub ahead of print).
   Google Scholar
• Videira M , BotelhoM, SantosA, GouveiaL, De Lima J, Almeida A: Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target10(8), 607–613 (2002).
   PubMed Web of Science ®Google Scholar
• Grenha A , Remuñán-LópezC, CarvalhoE, SeijoB: Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.Eur. J. Pharm. Biopharm.69(1), 83–93 (2008).
   PubMed Web of Science ®Google Scholar
• Faraji A , WipfP: Nanoparticles in cellular drug delivery.Bioorg. Med. Chem.17(8), 2950–2962 (2009).
   PubMed Web of Science ®Google Scholar
• Huang Y , WangC: Pulmonary delivery of insulin by liposomal carriers.J. Control. Release113(1), 9–14 (2006).
   PubMed Web of Science ®Google Scholar
• Bi R , ShaoW, WangQ, ZhangN: Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery.J. Drug Target16(9), 639–648 (2008).
   PubMed Web of Science ®Google Scholar
• Chono S , FukuchiR, SekiT, MorimotoK: Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery.J. Control. Release137(2), 104–109 (2009).
   PubMed Web of Science ®Google Scholar
• Shahiwala A , MisraA: A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: a technical note.AAPS PharmSciTech6(3), E482–E486 (2005).
   PubMed Web of Science ®Google Scholar
• Gilbert B , KnightC, AlvarezFet al.: Tolerance of volunteers to cyclosporine a-dilauroylphosphatidylcholine liposome aerosol.Am. J. Respir. Crit. Care Med.156(6), 1789–1793 (1997).
   PubMed Web of Science ®Google Scholar
• Khanna C , HaszD, KlausnerJ, AndersonP: Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: Canine studies.Clin. Cancer Res.2(4), 721–734 (1996).
   PubMed Web of Science ®Google Scholar
• Khanna C , AndersonP, HaszD, KatsanisE, NevilleM, KlausnerJ: Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases.Cancer79(7), 1409–1421 (1997).
   PubMed Web of Science ®Google Scholar
• Ten R , AndersonP, ZeinN, TemesgenZ, ClawsonM, WeissW: Interleukin-2 liposomes for primary immune deficiency using the aerosol route.Int. Immunopharmacol.2(2–3), 333–344 (2002).
   PubMed Web of Science ®Google Scholar
• Kaipel M , WagnerA, WassermannEet al.: Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs.J. Aerosol Med. Pulm. Drug Deliv.21(3), 281–290 (2008).
   PubMed Web of Science ®Google Scholar
• Lange C , HancockR, SamuelJ, FinlayW: In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.J. Pharm. Sci.90(10), 1647–1657 (2001).
   PubMed Web of Science ®Google Scholar
• Müller R , PetersenR, HommossA, PardeikeJ: Nanostructured lipid carriers (NLC) in cosmetic dermal products.Adv. Drug Deliv. Rev.59(6), 522–530 (2007).
   PubMed Web of Science ®Google Scholar
• Liu J , GongT, FuHet al.: Solid lipid nanoparticles for pulmonary delivery of insulin.Int. J. Pharm.356(1–2), 333–344 (2008).
   PubMedGoogle Scholar
• Liu Z , JiaoY, WangY, ZhouC, ZhangZ: Polysaccharides-based nanoparticles as drug delivery systems.Adv. Drug Deliv. Rev.60(15), 1650–1662 (2008).
   PubMed Web of Science ®Google Scholar
• Yang Y , BajajN, XuP, OhnK, TsifanskyM, YeoY: Development of highly porous large plga microparticles for pulmonary drug delivery.Biomaterials30(10), 1947–1953 (2009).
   PubMed Web of Science ®Google Scholar
• Huang X , DuY, YuanH, HuF: Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin.Carbohydr. Poly.76, 368–373 (2009).
   Web of Science ®Google Scholar
• Yamamoto H , HoshinaW, KurashimaHet al.: Engineering of poly(dl-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system.Adv. Powder Technol.18(2), 215–228 (2007).
   Web of Science ®Google Scholar
• Grenha A : Microencapsulación de nanopartículas de quitosano para la administración pulmonar de macromoléculas terapéuticas. Universidad de Santiago de Compostela, Facultad de Farmacia, Departamento de Farmacia y Tecnología Farmacéutica. PhD Thesis, 306 (2006).
   Google Scholar
• Zhang Q , ShenZ, NagaiT: Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.Int. J. Pharm.218(1–2), 75–80 (2001).
   PubMedGoogle Scholar
• Kawashima Y , YamamotoH, TakeuchiH, KunoY: Mucoadhesive DL/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin.Pharm. Dev. Technol.5(1), 77–85 (2000).
   PubMed Web of Science ®Google Scholar
• Yamamoto H , KunoY, SugimotoS, TakeuchiH, KawashimaY: Surface-modified plga nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.J. Control. Release102(2), 373–381 (2005).
   PubMed Web of Science ®Google Scholar
• Renwick L , BrownD, ClouterA, DonaldsonK: Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types.Occup. Environ. Med.61(5), 442–447 (2004).
   PubMed Web of Science ®Google Scholar
• Chang C : The immune effects of naturally occurring and synthetic nanoparticles.J. Autoimmun.34(3), J234–J246 (2010).
   PubMed Web of Science ®Google Scholar
• Thomas D , MyersM, WichertB, SchreierH, Gonzalez-RothiR: Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers.Chest99(5), 1268–1270 (1991).
   PubMed Web of Science ®Google Scholar
• Lizio R , KlennerT, SarlikiotisAet al.: Systemic delivery of cetrorelix to rats by a new aerosol delivery system.Pharm. Res.18(6), 771–779 (2001).
   PubMed Web of Science ®Google Scholar
• Niven R , WhitcombK, WoodwardM, LiuJ, JornacionC: Systemic absorption and activity of recombinant consensus interferons after intratracheal instillation and aerosol administration.Pharm. Res.12(12), 1889–1895 (1995).
   PubMed Web of Science ®Google Scholar
• Taljanski W , PierzynowskiS, LundinPet al.: Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine a to young and adult rats.Drug Metab. Dispos.25(8), 917–920 (1997).
   PubMed Web of Science ®Google Scholar
• Bennett D , TysonE, NerenbergC, MahS, De Groot J, Teitelbaum Z: Pulmonary delivery of detirelix by intratracheal instillation and aerosol inhalation in the briefly anesthetized dog. Pharm. Res.11(7), 1048–1055 (1994).
   PubMed Web of Science ®Google Scholar
• Schreier H , McnicolK, BennettD, TeitelbaumZ, DerendorfH: Pharmacokinetics of detirelix following intratracheal instillation and aerosol inhalation in the unanesthetized awake sheep.Pharm. Res.11(7), 1056–1059 (1994).
   PubMed Web of Science ®Google Scholar
• Patton JS , TrincheroP, PlatzRM: Bioavailability of pulmonary delivered peptides and proteins – α-interferon, calcitonins and parathyroid hormones.J. Control. Release28(1–3), 79–85 (1994).
   Web of Science ®Google Scholar
• Colthorpe P , FarrS, SmithI, WyattD, TaylorG: The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits.Pharm. Res.12(3), 356–359 (1995).
   PubMed Web of Science ®Google Scholar
• Pfützner A , MannA, SteinerS: Technosphere/insulin – a new approach for effective delivery of human insulin via the pulmonary route.Diabetes Technol. Ther.4(5), 589–594 (2002).
   PubMedGoogle Scholar
• Pang Y , SakagamiM, ByronP: The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition.Eur. J. Pharm. Sci.25(4–5), 369–378 (2005).
   PubMed Web of Science ®Google Scholar
• Rave K , BottS, HeinemannLet al.: Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.Diabetes Care28(5), 1077–1082 (2005)
   PubMed Web of Science ®Google Scholar
• Niven R , LottF, CribbsJ: Pulmonary absorption of recombinant methionyl human granulocyte colony stimulating factor (r-hug-csf) after intratracheal instillation to the hamster.Pharm. Res.10(11), 1604–1610 (1993).
   PubMed Web of Science ®Google Scholar
• Hubbard R , CrystalR: Strategies for aerosol therapy of α1-antitrypsin deficiency by the aerosol route.Lung168(Suppl.), 565–578 (1990).
   PubMedGoogle Scholar
• Kobayashi S , KondoS, JuniK: Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats.Pharm. Res.13(1), 80–83 (1996).
   PubMed Web of Science ®Google Scholar
• Lizio R , KlennerT, BorchardGet al.: Systemic delivery of the gnrh antagonist cetrorelix by intratracheal instillation in anesthetized rats.Eur. J. Pharm. Sci.9(3), 253–258 (2000).
   PubMed Web of Science ®Google Scholar
• Iacono A , JohnsonB, GrgurichWet al.: A randomized trial of inhaled cyclosporine in lung-transplant recipients.N. Engl. J. Med.354(2), 141–150 (2006).
   PubMed Web of Science ®Google Scholar
• Folkesson H , WeströmB, DahlbäckM, LundinS, KarlssonB: Passage of aerosolized bsa and the nona-peptide dDAVP via the respiratory tract in young and adult rats.Exp. Lung Res.18(5), 595–614 (1992).
   PubMed Web of Science ®Google Scholar
• Christopher F , ChaseD, SteinK, MilneR: Rhdnase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.J. Clin. Pharm. Ther.24(6), 415–426 (1999).
   PubMed Web of Science ®Google Scholar
• Bitonti A , DumontJ, LowSet al.: Pulmonary delivery of an erythropoietin fc fusion protein in non-human primates through an immunoglobulin transport pathway.Proc. Natl Acad. Sci. USA101(26), 9763–9768 (2004).
   PubMed Web of Science ®Google Scholar
• Russell K , ReadM, BellingerDet al.: Intratracheal administration of recombinant human factor ix (benefix) achieves therapeutic levels in hemophilia b dogs.Thromb. Haemost.85(3), 445–449 (2001).
   PubMed Web of Science ®Google Scholar
• Onoue S , YamamotoK, KawabataY, HiroseM, MizumotoT, YamadaS: Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.Int. J. Pharm.382(1–2), 144–150 (2009).
   PubMedGoogle Scholar
• Low S , NunesS, BitontiA, DumontJ: Oral and pulmonary delivery of fsh-fc fusion proteins via neonatal fc receptor-mediated transcytosis.Hum. Reprod.20(7), 1805–1813 (2005).
   PubMed Web of Science ®Google Scholar
• Codrons V , VanderbistF, UcakarB, PréatV, VanbeverR: Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1–34) from rat lungs.J. Pharm. Sci.93(5), 1241–1252 (2004).
   PubMed Web of Science ®Google Scholar
• Codrons V , VanderbistF, VerbeeckRet al.: Systemic delivery of parathyroid hormone (1–34) using inhalation dry powders in rats.J. Pharm. Sci.92(5), 938–950 (2003).
   PubMed Web of Science ®Google Scholar
• Van Zandwijk N , JassemE, DubbelmannR, BraatM, RumkeP: Aerosol application of interferon-α in the treatment of bronchioloalveolar carcinoma.Eur. J. Cancer26(6), 738–740 (1990).
   PubMed Web of Science ®Google Scholar
• Martin P , VaidyanathanS, LaneJet al.: Safety and systemic absorption of pulmonary delivered human ifn-β1a in the nonhuman primate: comparison with subcutaneous dosing.J. Interferon Cytokine Res.22(6), 709–717 (2002).
   PubMed Web of Science ®Google Scholar
• Halme M , MaasiltaP, RepoHet al.: Inhaled recombinant interferon-γ in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.Int. J. Radiat. Oncol. Biol. Phys.31(1), 93–101 (1995).
   PubMed Web of Science ®Google Scholar
• Eichelberg C , AndreasA, HeuerR, HulandH, HeinzerH, HulandE: Long-term tumor control with inhalational interleukin 2 therapy in cardiac high risk patients with metastatic renal carcinoma.J. Urol.179(4), 167–167 (2008).
   Web of Science ®Google Scholar
• Adjei A , SundbergD, MillerJ, ChunA: Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.Pharm. Res.9(2), 244–249 (1992).
   PubMed Web of Science ®Google Scholar
• Adjei A , GarrenJ: Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.Pharm. Res.7(6), 565–569 (1990).
   PubMed Web of Science ®Google Scholar
• Tazawa R , NakataK, InoueY, NukiwaT: Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.Respirology11(Suppl.) S61–S64 (2006).
   PubMed Web of Science ®Google Scholar

Patent

• MICRODRUG AG: US0120969 (2006).
   Google Scholar